Pull to refresh
Logo
Andrew Armstrong

Andrew Armstrong

Prostate cancer researcher and trial commentator

Appears in 1 story

Stories

Talazoparib trial moves a targeted prostate cancer drug to an earlier stage

New Capabilities

Public discussant of the TALAPRO-3 data

About one in four men with advanced prostate cancer carry inherited flaws in the genes that repair damaged DNA. A large trial now shows that giving those men a targeted pill alongside standard hormone therapy delays the cancer's spread by a wide margin.

Updated Yesterday